Extensive record keeping and database resources help make Fox Chase an ideal site for clinical studies. Protocol status is maintained in a centralized relational database accessible through the world wide web. In addition, a restricted access patient database provides detailed information about each of the over 5000 patients enrolled in trials. The patient database has been designed to enable data entry and generation of reports that include patient accrual, demographics, disease site, hospital site, and survival. Links have been established between the patient database and central hospital clinical laboratory database, permitting rapid retrieval of laboratory data for protocol patients.
All protocols are subject to a two tier examination process.
The Fox Chase Review Committee conducts initial protocol assessments of scientific merit, design, feasibility, and statistical analysis. Following approval, all protocols are subjected to final evaluation by out Institutional Review Board. Annual reviews of all active protocols are conducted using an NCI-approved Clinical Protocol Scientific Review and Monitoring System. Material transfer agreements define and protect the rights of both parties with respect to the transferred materials. MTA's for materials coming into or going out from Fox Chase are reviewed and negotiated by the Office of Business Development to ensure that they conform with Fox Chase intellectual property and research policies.